Halozyme Therapeutics Inc (HALO)
59.51
-0.26
(-0.44%)
USD |
NASDAQ |
Apr 07, 10:33
Halozyme Therapeutics Price: 59.51 for April 7, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biomarin Pharmaceutical Inc | 58.85 |
| Johnson & Johnson | 149.60 |
| Catalyst Pharmaceuticals Inc | 22.08 |
| Merck & Co Inc | 81.27 |
| Semler Scientific Inc | 33.16 |
Price Related Metrics
| PE Ratio | 17.35 |
| PS Ratio | 7.581 |
| PEG Ratio | 0.2773 |
| Price to Book Value | 20.14 |
| Price to Free Cash Flow | 16.43 |
| Earnings Yield | 5.76% |
| Market Cap | 7.329B |
| PEGY Ratio | 0.2773 |
| Operating PE Ratio | 13.96 |
| Normalized PE Ratio | 18.12 |